nach oben

Journal of Neuro-Oncology

Erschienen in:

01.02.2014 | Laboratory Investigation

Does the existence of HCMV components predict poor prognosis in glioma?

verfasst von: Daling Ding, Sheng Han, Zixun Wang, Zongze Guo, Anhua Wu

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Human cytomegalovirus (HCMV) has been associated with malignant gliomas. The objective of the present study was to further investigate the existence and prognostic value of HCMV components in gliomas. Using immunohistochemical staining, HCMV proteins IE1-72 and pp65 were examined in 67 glioma specimens of various histologic grades, in comparison to 6 -control brain tissue samples. The HCMV DNA was measured in both the tumor tissues and the peripheral blood of the patients, using nested PCR. Kaplan–Meier analysis and Cox proportional hazards models were used to analyzed the prognostic value of HCMV components in glioma tissues. IE1-72 was detected in 76.1 % (51/67) of glioma tissues, and pp65 was detected in 65.7 % (44/67) of glioma tissues. HCMV DNA was detected in 52.2 % (35/67) of glioma tissues and 29.9 % (20/67) of peripheral blood samples of glioma patients. These HCMV components were not detected in control brain tissue. However, the existence of HCMV components showed no significant correlation with the prognosis of glioma patients. Our results demonstrate that although HCMV proteins and nucleic acids are present in gliomas, they do not correlate with the prognosis. The role of HCMV in gliomas needs to be carefully interpreted.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef

Cobbs CS (2011) Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae 2:10PubMedCentralPubMedCrossRef

Zur HH (2009) The search for infectious causes of human cancers: where and why. Virology 392:1–10CrossRef

Alibek K, Kakpenova A, Baiken Y (2013) Role of infectious agents in the carcinogenesis of brain and head and neck cancers. Infect Agent Cancer 8:7PubMedCentralPubMedCrossRef

Are C, Rajaram S, Are M, Raj H, Anderson BO, Chaluvarya SR, Vijayakumar M, Song T, Pandey M, Edney JA, Cazap EL (2013) A review of global cancer burden: trends, challenges, strategies, and a role for surgeons. J Surg Oncol 107:221–226PubMedCrossRef

Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79–86PubMedCentralPubMedCrossRef

Soderberg-Naucler C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer. J Intern Med 259:219–246PubMedCrossRef

Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350PubMed

Jarvis MA, Wang CE, Meyers HL, Smith PP, Corless CL, Henderson GJ, Vieira J, Britt WJ, Nelson JA (1999) Human cytomegalovirus infection of caco-2 cells occurs at the basolateral membrane and is differentiation state dependent. J Virol 73:4552–4560PubMedCentralPubMed

10.

Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237–238PubMedCrossRef

11.

Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59:793–797PubMed

12.

Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 10:10–18PubMedCentralPubMedCrossRef

13.

Johnsen JI, Baryawno N, Soderberg-Naucler C (2011) Is human cytomegalovirus a target in cancer therapy. Oncotarget 2:1329–1338PubMed

14.

Javier RT, Butel JS (2008) The history of tumor virology. Cancer Res 68:7693–7706PubMedCentralPubMedCrossRef

15.

McLaughlin-Drubin ME, Munger K (2008) Viruses associated with human cancer. Biochim Biophys Acta 1782:127–150PubMedCentralPubMedCrossRef

16.

Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557–1563PubMedCrossRef

17.

Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998–1002PubMedCrossRef

18.

Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359:539–541PubMedCentralPubMedCrossRef

19.

Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjornsson B, FuskevAg OM, Segerstrom L, Nordenskjold M, Siesjo P, Kogner P, Johnsen JI, Soderberg-Naucler C (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121:4043–4055PubMedCentralPubMedCrossRef

20.

Melnick M, Sedghizadeh PP, Allen CM, Jaskoll T (2012) Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp Mol Pathol 92:118–125PubMedCrossRef

21.

Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843PubMedCrossRef

22.

Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Tremoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750PubMedCentralPubMedCrossRef

23.

Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99PubMedCrossRef

24.

Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor DSR, Smit M, Soroceanu L, Cobbs CS (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol 14:246–255PubMedCentralPubMedCrossRef

25.

Soroceanu L, Cobbs CS (2011) Is HCMV a tumor promoter. Virus Res 157:193–203PubMedCentralPubMedCrossRef

26.

Hawkins C, Croul S (2011) Viruses and human brain tumors: cytomegalovirus enters the fray. J Clin Invest 121:3831–3833PubMedCentralPubMedCrossRef

Titel: Does the existence of HCMV components predict poor prognosis in glioma?
verfasst von: Daling Ding
Sheng Han
Zixun Wang
Zongze Guo
Anhua Wu
Publikationsdatum: 01.02.2014
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2014
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-013-1350-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option

TET family proteins: new players in gliomas

Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology)

Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma

Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing’s disease

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models